https://www.selleckchem.com/pr....oducts/shin1-rz-2994
Umbilical cord blood is an established source of stem cells in patients with hematologic malignancies who do not have HLA-compatible matched related or unrelated donors. The success of an umbilical cord blood transplant depends on the dose of total nucleated and CD34+ cells infused. Therefore, collecting, banking and listing high-quality cord blood units with high total nucleated and CD34+ cell dose are essential. Here the authors describe their cord blood bank's novel collection technique, which involves both in utero and ex uter
Like
Comment
Share
